• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Afro-Egyptian Journal of Infectious and Endemic Diseases
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2025)
Volume Volume 14 (2024)
Volume Volume 13 (2023)
Volume Volume 12 (2022)
Volume Volume 11 (2021)
Volume Volume 10 (2020)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 9 (2019)
Volume Volume 8 (2018)
Volume Volume 7 (2017)
Volume Volume 6 (2016)
Volume Volume 5 (2015)
Volume Volume 4 (2014)
Volume Volume 3 (2013)
Volume Volume 2 (2012)
Volume Volume 1 (2011)
El-Toukhy, N., Abd-Alrahman, M., Eissa, H. (2020). Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma. Afro-Egyptian Journal of Infectious and Endemic Diseases, 10(3), 294-300. doi: 10.21608/aeji.2020.23205.1049
Naglaa El-Toukhy; Mona Youssef Abd-Alrahman; Hesham A Eissa. "Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma". Afro-Egyptian Journal of Infectious and Endemic Diseases, 10, 3, 2020, 294-300. doi: 10.21608/aeji.2020.23205.1049
El-Toukhy, N., Abd-Alrahman, M., Eissa, H. (2020). 'Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma', Afro-Egyptian Journal of Infectious and Endemic Diseases, 10(3), pp. 294-300. doi: 10.21608/aeji.2020.23205.1049
El-Toukhy, N., Abd-Alrahman, M., Eissa, H. Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2020; 10(3): 294-300. doi: 10.21608/aeji.2020.23205.1049

Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma

Article 9, Volume 10, Issue 3, September 2020, Page 294-300  XML PDF (279.63 K)
Document Type: Original Article
DOI: 10.21608/aeji.2020.23205.1049
View on SCiNiTO View on SCiNiTO
Authors
Naglaa El-Toukhy1; Mona Youssef Abd-Alrahman email 2; Hesham A Eissa3
1Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Benha University, Egypt.
2Department of Hepatology and Gastroenterology, Benha Teaching Hospital, Egypt.
3Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Egypt.
Abstract
Background and study aim: Hepatocellular carcinoma (HCC) is the most common type of primary liver tumors. In Egypt, it is the second most common cancer in men, and the sixth most frequent cancer in women. Prognosis of HCC depends on tumor stage, with curative therapies effective only in early stage; thus, new and appropriate HCC markers are highly required. The aim was to evaluate serum diagnostic value Golgi Protein 73 in Egyptian HCC patients.
Patients and Methods: This study included 30 HCC patients, 30 cirrhotic patients and 20 healthy controls. For all groups clinical data and imaging results were studied; serum alpha-fetoprotein and Golgi Protein 73 were identified. Evaluation of the tumor characteristics including size, number and location. Okuda, CLIP and Tokyo staging methods used in tumor staging.
Results: GP73 was significantly higher in HCC patients compared to cirrhotic patients and controls. Its sensitivity and specificity in HCC diagnosis were 95% and 83.3%, respectively, at cut-off 5.8%. There is a positive correlation between GP73 and Okuda score and ClIP score and no correlations with number and size of the tumor, child's classification, MELD, uMELD and Tokyo stages.
Conclusion: GP73 could be a useful diagnostic marker for detection and screening of HCC.
Keywords
Hepatocellular carcinoma; GP73; Alpha-fetoprotein
Main Subjects
Hepatology
Statistics
Article View: 315
PDF Download: 533
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.